Meet Our Scientific Advisory Board.

Our SAB thought leaders provide an in-depth expertise in clinical development and global registration strategies for novel anti-epileptic drugs. Their insights will be invaluable as Marinus approaches key pipeline milestones.

Jacqueline French, M.D.

Professor of Neurology in the Comprehensive Epilepsy Center at NYU Langone School of Medicine and Founder/Director of the Epilepsy Study Consortium, an academic group that has performed several early phase clinical trials in epilepsy. Dr. French trained in Neurology at Mount Sinai Hospital in New York and did her fellowship training in EEG and epilepsy at Mount Sinai hospital and Yale University. Over the past 20 years Dr. French has served as the Principle investigator on several trials for new epilepsy drugs and has focused her research efforts developing new therapeutics for epilepsy and novel methodologies for clinical trials. Dr. French, who serves as Chief Medical/Innovation Officer for the Epilepsy Foundation, has been active in creating guidelines for the American Academy of Neurology and the International League Against Epilepsy. She is the editor of three books and has authored over 300 articles and chapters.

Lawrence Hirsch, M.D.

Professor of Neurology, Chief of Division of Epilepsy and Electroencephalography (EEG), and Co-Director of the Yale Comprehensive Epilepsy Center. He has held leadership positions at the American Clinical Neurophysiology Society (ACNS), American Epilepsy Society, American Academy of Neurology and the Epilepsy Foundation, and is founder and former chair of the Critical Care EEG Monitoring Research Consortium, which now includes more than 50 centers across North America. He is lead author of the ACNS guideline on critical care EEG terminology, and has been an active researcher throughout his career, having published more than 150 original research manuscripts and more than 100 reviews, editorials or book chapters on topics including status epilepticus, EEG, and antiepileptic drugs. Dr. Hirsch is co-author of the first-ever atlas on EEG in critical care.

Aatif Husain, M.D.

Professor of Neurology and Division Chief of Epilepsy, Sleep, and Clinical Neurophysiology at the Duke University School of Medicine, is a world-renowned expert in clinical neurophysiology, with experience serving as president of the American Clinical Neurophysiology Society, treasurer of the International Federation of Clinical Neurophysiology. Through his research Dr. Husain has been highly influential in the developing treatments for seizures, with landmark studies on the treatment of refractory seizures and non-convulsive status epilepticus. Amongst the more than 100 publications and nine books he has authored, he is also the editor-in-chief of the Journal of Clinical Neurophysiology.

Michael Rogawski M.D., Ph.D.

Professor of Neurology and Pharmacology at the University of California, Davis School of Medicine is an internationally recognized expert on drug discovery and development for epilepsy, with a research focus on neuroactive steroids. He serves as lead of the University of California Drug Discovery Consortium. Dr. Rogawski was formerly chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke. He received his M.D. and Ph.D. (pharmacology) from Yale and trained in neurology at Johns Hopkins. He has served on the board of directors of the American Epilepsy Society and has been a member of advisory panels to the National Institutes of Health. He has authored more than 275 research papers, reviews, and book chapters, and edited five books.

Eugen Trinka, M.D.

Professor and Chairman of the Department of Neurology, Christian Doppler University Hospital at the Paracelsus Medical University in Salzburg, Austria. Dr. Trinka’s research interests include clinical epileptology with a focus on epidemiology, prognosis, epilepsy surgery, and status epilepticus. He is the founding member of the European Epilepsy Consortium, dedicated to clinical drug trials in the field of epilepsy and has authored more than 480 scientific publications and book chapters, including the seminal paper describing the diagnostic criteria for non-convulsive status epilepticus called the Salzburg criteria. Dr. Trinka is the current President of the Austrian Society of Neurology, past president of the Austrian Society for Epilepsy, Austrian Society for Clinical Neurophysiology and the Society of Epilepsy Surgery Centres in Germany, Austria. He has been elected as Chair of ILAE-EUROPE in 2017. He also serves on the ILAE Task force of Classification of Status Epilepticus, the Commission on Medical Treatment, the ILAE Working group on pre-clinical drug discovery, and the ILAE Task Force on Regulatory affairs.

Henrikas Vaitkevicius, M.D.

is an Attending Neurologist in the Neurocritical Care, Hospital Neurology, Neurological Infections, Inflammatory Diseases, and Stroke Divisions of Brigham and Women’s Hospital Department of Neurology. Dr. Vaitkevicius, who is also an Assistant Professor at Harvard Medical School, received his graduate and medical school training at Wayne State University in Detroit, MI. He completed his neurology residency and neurocritical care fellowship at Brigham & Women’s and Mass General Hospital in Boston, MA. Dr. Vaitkevicius has appeared in 38 peer-reviewed publications, five non-peer reviewed scientific or medical materials, and in 2015 was an ad hoc reviewer for the New England Journal of Medicine. He serves as the Director of Brain Hub: Studio for Research and Innovation in Critical Care Neurology where he focuses on fostering collaborations among academic departments and pharmaceutical industries to bring novel treatments to the bedside.